Faes Farma increases its profit by 4% after boosting its global businesses
In addition to R&D&I, the pharmaceutical company is committed to an Industrial Plan as a “key lever” for the reinforcement and growth of production capacities in a “complex” macroeconomic context. Faes Farma’s net profit rises 4% in the first quarter to almost 30 million euros Faes Farma reported a net profit of 27.6…